Predictors of treatment response in lymphogenic metastasized papillary thyroid cancer: a histopathological study
European Journal of Endocrinology · 2024
DOI: 10.1093/ejendo/lvae048 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Endocrinology, 2024. Verfasst von Caroline M J van Kinschot und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Maasstad Hospital, 3079 DZ Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Lymphatic Metastasis, Thyroid Cancer, Papillary, Carcinoma, Papillary. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Lymph node metastases in papillary thyroid cancer (PTC) increase the risk for persistent and recurrent disease. Data on the predictive value of histopathological features of lymph node metastases, however, are inconsistent. The aim of this study was to evaluate the prognostic significance of known and new histopathological features of lymph node metastases in a well-defined cohort of PTC patients with clinically evident lymph node metastases.
Methods
A total of 1042 lymph node metastases, derived from 129 PTC patients, were reexamined according to a predefined protocol and evaluated for diameter, extranodal extension, cystic changes, necrosis, calcifications, and the proportion of the lymph node taken up by tumor cells. Predictors for a failure to achieve a complete biochemical and structural response to treatment were determined.
Results
The presence of more than 5 lymph node metastases was the only independent predictor for a failure to achieve a complete response to treatment (odds ratio [OR] 3.39 [95% CI, 1.57-7.33], P < .05). Diameter nor any of the other evaluated lymph node features were significantly associated with the response to treatment.
Conclusions
Detailed reexamination of lymph nodes revealed that only the presence of more than 5 lymph node metastases was an independent predictor of failure to achieve a complete response to treatment. No predictive value was found for other histopathological features, including the diameter of the lymph node metastases. These findings have the potential to improve risk stratification in patients with PTC and clinically evident lymph node metastases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Maasstad Hospital, 3079 DZ Rotterdam, The Netherlands.
- Academic Center for Thyroid Diseases, Department of Internal Medicine, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.
- Academic Center for Thyroid Diseases, Department of Pathology, Erasmus Medical Center, 3079 DZ Rotterdam, The Netherlands.
- Department of Pathology, Laboratory for Pathology Dordrecht, 3318 AL Dordrecht, The Netherlands.
ORCID-Profile: Caroline M J van Kinschot, Lindsey Oudijk, W Edward Visser
Zitieren
APA
van Kinschot, C. M. J., Oudijk, L., van Noord, C., Korevaar, T. I. M., van Nederveen, F. H., Peeters, R. P., van Kemenade, F. J., & Visser, W. E. (2024). Predictors of treatment response in lymphogenic metastasized papillary thyroid cancer: a histopathological study. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvae048
Vancouver
van Kinschot CMJ, Oudijk L, van Noord C, Korevaar TIM, van Nederveen FH, Peeters RP, et al. Predictors of treatment response in lymphogenic metastasized papillary thyroid cancer: a histopathological study. European Journal of Endocrinology. 2024. doi:10.1093/ejendo/lvae048
BibTeX
@article{vanKinschot2024,
author = {van Kinschot, Caroline M J and Oudijk, Lindsey and van Noord, Charlotte and Korevaar, Tim I M and van Nederveen, Francien H and Peeters, Robin P and van Kemenade, Folkert J and Visser, W Edward},
title = {Predictors of treatment response in lymphogenic metastasized papillary thyroid cancer: a histopathological study},
journal = {European Journal of Endocrinology},
year = {2024},
doi = {10.1093/ejendo/lvae048}
}
EUVIMED